Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 TrialsClaire Gallois, Demetris Papamichael, Jeffrey A. Meyerhardt et al.|Journal of Clinical Oncology|2024Cited by 25
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical TrialsSarah C. Rutherford, John P. Leonard, Jun Yin et al.|Journal of Clinical Oncology|2022Cited by 18
Outcomes in the second line treatment of metastatic colorectal cancer (mCRC): Findings from 6,462 patients (pts) in the ARCAD database.Alexis D. Leal, Axel Grothey, Fang‐Shu Ou et al.|Journal of Clinical Oncology|2017Cited by 1
Assessing outcome differences in the second line treatment of metastatic colorectal cancer (mCRC): An ARCAD analysis comparing sequence after first line trials (SAFL) and dedicated second line trials (DSLT).Alexis D. Leal, Axel Grothey, Fang‐Shu Ou et al.|Journal of Clinical Oncology|2017Cited by 0